Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.
|
Biol Psychiatry
|
2013
|
1.58
|
2
|
Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD.
|
Neurology
|
2012
|
1.49
|
3
|
Contribution of right hemisphere to visual imagery: a visual working memory impairment?
|
J Int Neuropsychol Soc
|
2008
|
1.44
|
4
|
5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents.
|
Bioorg Med Chem
|
2005
|
1.29
|
5
|
Trinuclear heterobimetallic complexes with binucleating dithioxamides: stereoselective synthesis and solution behavior involving Pd-N bond rupture.
|
Inorg Chem
|
2003
|
1.18
|
6
|
Exact distinction of excitatory and inhibitory neurons in neural networks: a study with GFP-GAD67 neurons optically and electrophysiologically recognized on multielectrode arrays.
|
Front Neural Circuits
|
2012
|
1.18
|
7
|
The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
|
J Alzheimers Dis
|
2013
|
0.98
|
8
|
catena-Poly[bis-(4-amino-pyridinium) [[tetra-aqua-nickel(II)]-μ-benzene-1,2,4,5-tetra-carboxyl-ato] dihydrate].
|
Acta Crystallogr Sect E Struct Rep Online
|
2009
|
0.97
|
9
|
N,N'-Dibenzyl-N,N'-dimethyl-N''-(methyl-sulfon-yl)phospho-ric triamide.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.96
|
10
|
4-[(4-Chloro-phen-yl)diazen-yl]-3-meth-oxy-aniline.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.95
|
11
|
Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients.
|
J Alzheimers Dis
|
2012
|
0.88
|
12
|
Allylpalladium dimers with metals connected by binucleating dithiooxamidates in two different coordination modes: solution behavior and solid-state structure.
|
Inorg Chem
|
2011
|
0.88
|
13
|
Regio and diastereoselective lactonisation of enolisable 1,3-dicarbonyls by reaction with mesoionic 1,3-oxazolium-5-olates.
|
Chem Commun (Camb)
|
2003
|
0.88
|
14
|
3-(2-Eth-oxy-phen-yl)-1-(3-nitro-phen-yl)triaz-1-ene.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.88
|
15
|
N,N-Dimethyl-propane-1,2-diaminium bis-(6-carb-oxy-pyridine-2-carboxyl-ate) monohydrate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.88
|
16
|
2,3-Diamino-pyridinium 6-carb-oxy-pyridine-2-carboxyl-ate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.86
|
17
|
Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.
|
AIDS Res Hum Retroviruses
|
2014
|
0.83
|
18
|
A novel mutation in the predicted TMIII domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer's disease.
|
J Alzheimers Dis
|
2010
|
0.82
|
19
|
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units.
|
PLoS One
|
2012
|
0.82
|
20
|
Functional and structural characterization of ovine ornithine transcarbamoylase.
|
Org Biomol Chem
|
2003
|
0.82
|
21
|
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
|
J Med Chem
|
2003
|
0.81
|
22
|
Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory.
|
Int J Geriatr Psychiatry
|
2012
|
0.81
|
23
|
Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.
|
J Alzheimers Dis
|
2013
|
0.80
|
24
|
X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.
|
BMC Infect Dis
|
2013
|
0.80
|
25
|
New Adducts of Dirhodium(II) Formamidinate Complexes with Polycyano Acceptor Molecules. X-ray Crystal Structure of the Tricyanomethanide Complex Rh(2)(form)(4)[C(CN)(3)] (form = N,N'-Di-p-tolylformamidinate).
|
Inorg Chem
|
1997
|
0.79
|
26
|
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.
|
Neurobiol Aging
|
2013
|
0.79
|
27
|
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.
|
J Neurol
|
2013
|
0.77
|
28
|
Rivastigmine in the treatment of hypersexuality in Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2013
|
0.77
|
29
|
Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
|
J Alzheimers Dis
|
2011
|
0.77
|
30
|
Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease.
|
Neurol Sci
|
2011
|
0.77
|
31
|
Dithioether ligands containing a 2,6-disubstituted pyridine linker with two thioether-heterocycle arms.
|
Acta Crystallogr C
|
2009
|
0.76
|
32
|
Cognitive interventions targeting subjective cognitive complaints.
|
Am J Alzheimers Dis Other Demen
|
2013
|
0.76
|
33
|
A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects.
|
J Neuroinflammation
|
2014
|
0.76
|
34
|
Diosmin binding to human serum albumin and its preventive action against degradation due to oxidative injuries.
|
Biochimie
|
2013
|
0.76
|
35
|
(Dipyrido[3,2-a:2',3'-c]phenazine)(glycinato)copper(II) perchlorate: a novel DNA-intercalator with anti-proliferative activity against thyroid cancer cell lines.
|
J Inorg Biochem
|
2012
|
0.76
|
36
|
1-[((E)-{2-[(2-Nitro-benz-yl)(2-{[(E)-(2-oxidonaphthalen-1-yl)methyl-idene]aza-nium-yl}eth-yl)amino]-eth-yl}aza-niumyl-idene)meth-yl]naphthalen-2-olate monohydrate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
37
|
N-(3-Fluoro-benzo-yl)-N',N''-bis-(4-methyl-phen-yl)phospho-ric triamide.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
38
|
Chlorido(η-cyclo-octa-1,5-diene)(N,N'-diethyl-thio-urea-κS)rhodium(I).
|
Acta Crystallogr Sect E Struct Rep Online
|
2010
|
0.75
|
39
|
N-(2-Eth-oxy-phen-yl)formamide.
|
Acta Crystallogr Sect E Struct Rep Online
|
2012
|
0.75
|
40
|
Bis[1-(2-eth-oxy-phen-yl)-3-(4-nitro-phen-yl)triazenido]mercury(II).
|
Acta Crystallogr Sect E Struct Rep Online
|
2010
|
0.75
|
41
|
Bis[2-(2-amino-ethyl-amino)-ethanol]copper(II) dinitrate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
42
|
[(Z)-1-({3-[(3-Amino-prop-yl)(2-nitro-benz-yl)amino]-prop-yl}imino-meth-yl)naphthalen-2-olato]copper(II) perchlorate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
43
|
A functionalized enol lactone containing a protected α-amino acid.
|
Acta Crystallogr Sect E Struct Rep Online
|
2010
|
0.75
|
44
|
Diphenyl (cyclo-pentyl-amido)-phospho-nate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
45
|
Tetra-kis(μ-4-chloro-benzoato-κ(2) O:O')bis-[(ethanol-κO)copper(II)](Cu-Cu).
|
Acta Crystallogr Sect E Struct Rep Online
|
2013
|
0.75
|
46
|
Methyl 2-{2-[(E)-(2-hy-droxy-3-meth-oxy-benzyl-idene)amino]-ethyl-amino}-cyclo-pentene-1-carbodithio-ate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
47
|
N,N'-Dicyclo-hexyl-N''-(3-fluoro-benzo-yl)-N,N'-dimethyl-phospho-ric triamide.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
48
|
(S)-2-[(2-Hy-droxy-benz-yl)aza-nium-yl]-4-(methyl-sulfan-yl)butano-ate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
49
|
3-(4-Bromo-anilino)-3-(4-chloro-phen-yl)-1-phenyl-propan-1-one.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
50
|
Propane-1,2-diaminium bis-(pyridine-2,6-dicarboxyl-ato-κO,N,O)mercurate(II) dihydrate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
51
|
catena-Poly[[[μ-aqua-penta-aqua-dizinc(II)]-μ(4)-benzene-1,2,4,5-tetra-carboxyl-ato] dihydrate].
|
Acta Crystallogr Sect E Struct Rep Online
|
2009
|
0.75
|
52
|
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4'-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists.
|
Bioorg Med Chem
|
2007
|
0.75
|
53
|
A new tridentate Schiff base Cu(II) complex: synthesis, experimental and theoretical studies on its crystal structure, FT-IR and UV-Visible spectra.
|
Spectrochim Acta A Mol Biomol Spectrosc
|
2013
|
0.75
|
54
|
Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer's disease case.
|
J Neurol
|
2011
|
0.75
|
55
|
Effect of chelating vs. bridging coordination of chiral short-bite P-X-P (X=C, N, O) ligands in enantioselective palladium-catalysed allylic substitution reactions.
|
Dalton Trans
|
2003
|
0.75
|
56
|
The absolute configuration of palladium(II) and ruthenium(II) pseudochiral centers in either chiral or achiral environments.
|
Inorg Chem
|
2010
|
0.75
|
57
|
[Use of neuropsychological tests in the Cronos Project].
|
Ann Ist Super Sanita
|
2005
|
0.75
|
58
|
Origin of enantioselectivity in palladium-catalyzed asymmetric allylic alkylation reactions using chiral N,N-ligands with different rigidity and flexibility.
|
Dalton Trans
|
2007
|
0.75
|
59
|
Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
|
Neurol Sci
|
2008
|
0.75
|
60
|
Charge injection into nanostructured TiO2 electrodes from the photogenerated reduced form of a new Ru(ii) polypyridine compound: the "anti-biomimetic" mechanism at work.
|
Dalton Trans
|
2016
|
0.75
|
61
|
Enantioseparation, absolute configuration determination, and anticonvulsant activity of (+/-)-1-(4-aminophenyl)-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-one.
|
Chirality
|
2007
|
0.75
|
62
|
Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.
|
J Med Chem
|
2011
|
0.75
|
63
|
[Evidence-based prevention: a new model for public health].
|
Ig Sanita Pubbl
|
2007
|
0.75
|
64
|
Three new [XC(O)NH]P(O)[N(CH2C6H5)2]2 phosphoric triamides (X = CClF2, 3-F-C6H4 and 3,5-F2-C6H3): a database analysis of tertiary N-atom geometry in compounds with a C(O)NHP(O)[N]2 core.
|
Acta Crystallogr C
|
2012
|
0.75
|
65
|
Predicting the Rate of Cognitive Decline in Alzheimer Disease: Data From the ICTUS Study.
|
Alzheimer Dis Assoc Disord
|
2016
|
0.75
|